Latest Stories
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
1 Software Stock to Own for Decades and 2 We Ignore
Software is rapidly reducing operating expenses for businesses. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to raise capital. But this was a double-edged sword as the high prices exposed them to big drawdowns, and unfortunately, the industry has tumbled by 22% over the last six months. This performance is a stark contrast from the S&P 500’s 6% gain.
3 Reasons Investors Love Trane Technologies (TT)
Trane Technologies has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.9% to $471.48 per share while the index has gained 6%.
GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?
GoodRx’s stock price has taken a beating over the past six months, shedding 56.5% of its value and falling to $2.23 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Nelnet (NNI): 3 Reasons We Love This Stock
Nelnet currently trades at $130.98 per share and has shown little upside over the past six months, posting a middling return of 3%.
3 Reasons to Sell ALV and 1 Stock to Buy Instead
Autoliv has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 5.5% to $125.43 per share while the index has gained 6%.
3 Reasons to Sell LW and 1 Stock to Buy Instead
Over the last six months, Lamb Weston’s shares have sunk to $48.00, producing a disappointing 11.6% loss - a stark contrast to the S&P 500’s 6% gain. This might have investors contemplating their next move.
3 Reasons to Sell ASLE and 1 Stock to Buy Instead
Over the past six months, AerSale’s stock price fell to $7.37. Shareholders have lost 16.6% of their capital, which is disappointing considering the S&P 500 has climbed by 6%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
2 Reasons to Like GWRE (and 1 Not So Much)
Guidewire Software has gotten torched over the last six months - since August 2025, its stock price has dropped 42.5% to $123.70 per share. This might have investors contemplating their next move.
2 Reasons CME is Risky and 1 Stock to Buy Instead
Over the past six months, CME Group has been a great trade, beating the S&P 500 by 6.1%. Its stock price has climbed to $303.07, representing a healthy 12.1% increase. This run-up might have investors contemplating their next move.